Navigation Links
Lupin Gets Tentative Nod from FDA for Antidepressant Drug

Leading pharmaceutical company Lupin Ltd has received tentative approval from the US Food and Drug Administration (FDA) for its generic drug Sertraline Hydrochloride for// treatment of major depressive disorder.

Mumbai based Lupin's Sertraline Hydrochloride tablets will be the AB-rated generic equivalent of Pfizer's Zoloft tablets of 25mg, 50mg and 100mg dosage.

"The company intends to launch the generic (drug) on final approval, which is expected upon expiration of the marketing exclusivity (of Pfizer's Zoloft) for the product in February 2007," a company statement said here Tuesday.

This is Lupin's 18th Abbreviated New Drug Application (ANDA) to have received US FDA approval till date.

The company is a leading global player in anti-tuberculosis, cephalosporins (anti-infectives) and cardiovascular drugs (prils and statins) and has a notable presence in the areas of diabetology, non-steroidal anti-inflammatory drugs (NSAIDS) and asthma.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Lupin flour may cause peanut allergy like reactions
2. Lupin Gets USFDA Approval For Quinapril Tablets
3. US Court Rules Against Lupin in Ramipril Patent Case
4. Lupin Gets USFDA Approval for Meloxicam
5. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
6. Tentative inhaled steroids is worse for lung patients
7. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
8. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Antidepressant helps obesity
11. Antidepressants increase gastric bleeding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes and ... around the nation. What do they have in common? All have been affected by ... new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... connectors, is now promoting to the US market its advanced highly customizable contact ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range ...
(Date:12/7/2016)... MI (PRWEB) , ... December 07, 2016 , ... ... and financial consultation services from offices located in South Lyon, Dewitt, Williamston, East ... benefit a basketball coach who needs treatment for a brain tumor. , Jason ...
(Date:12/7/2016)... Folsom, CA (PRWEB) , ... December 07, 2016 ... ... that provides insurance and financial consultation services to residents in the Sacramento/Folsom region, ... Choice Another Chance treatment facility. , The Another Choice Another Chance treatment center ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... present a company overview at the BMO Capital Markets Prescriptions for ... York, NY . A live webcast of the ... the Ionis website.  The replay will be available within 48 hours ... ...
(Date:12/7/2016)... 7, 2016 Today, Stock-Callers.com presents four ... JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ... AveXis Inc. (NASDAQ: AVXS ). From its peak ... 37% to reach a level equal to what it saw ... approximately 14% for the year, it has still out-performed other ...
(Date:12/7/2016)... According to the latest market ... Study on Multiplex Detection Immunoassay: North America to Dominate ... detection immunoassay market is expected to witness a CAGR of ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
Breaking Medicine Technology: